Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Delaware Zantac Lawsuits Continue To Be Filed As GlaxoSmithKline Appeals to State Supreme Court Drug maker is challenging a lower court ruling, which allows Zantac lawsuits in Delaware to move forward to trial over the increased risk of cancer caused by the recalled heartburn medication. August 28, 2024 Irvin Jackson Add Your Comments The Delaware Supreme Court has agreed to hear an interlocutory appeal filed by GlaxoSmithKline (GSK), which seeks to overturn a lower court’s ruling that cleared the way for tens of thousands of Zantac lawsuits over cancers caused by the heartburn drug to be brought before juries in the state. The announcement that the highest court in the state will consider the appeal comes as a steady flow of new complaints continue to be filed in Delaware, where there are already more than 75,000 lawsuits pending that involve claims that Zantac caused users to develop bladder cancer, liver cancer, colon cancer, pancreatic cancer, stomach cancer and other injuries. The litigation emerged after all versions of Zantac were recalled from the market more than four years ago, following the discovery that the active pharmaceutical ingredient in the pills, ranitidine, is inherently unstable and produces high levels of the chemical byproduct N-Nitrosodimethylamine (NDMA), which is a known human carcinogen. Plaintiffs maintain that GSK and other drug makers knew or should have known about the Zantac cancer risks, yet failed to reformulate their products and continued to market the drug for treatment of heartburn and acid reflux for years. However, GSK is attempting to challenge the Delaware Zantac lawsuits by urging the state Supreme Court to exclude all plaintiffs’ expert witnesses from testifying under state-specific evidentiary standards. Stay Up-to-Date About Zantac Lawsuits AboutLawsuits.com sends a weekly digest email with information about recalls, lawsuits, and safety warnings that may impact your family, including any new Zantac lawsuit updates or legal developments. "*" indicates required fields Email* SIGN ME UP Δ Learn More Stay Up-to-Date About Zantac Lawsuits AboutLawsuits.com sends a weekly digest email with information about recalls, lawsuits, and safety warnings that may impact your family, including any new Zantac lawsuit updates or legal developments. "*" indicates required fields Email* SIGN ME UP Δ Learn More The Zantac litigation was initially focused in the federal court system, where claims brought in U.S. District Courts nationwide were centralized before U.S. District Judge Robin L. Rosenberg for coordinated discovery and pretrial proceedings. However, before the first federal case ever reached trial, Judge Rosenberg issued a controversial ruling determining that there was not sufficiently reliable expert testimony to establish that Zantact caused any cancer diagnosis among plaintiffs. Judge Rosenberg’s decision was based on an interpretation of the federal rules regarding the admissibility of expert testimony, resulting in the dismissal of all federal Zantac lawsuits. However, the ruling had no impact on claims that continued to be filed in various different state court systems, including Delaware, Illinois and Connecticut, where judges have already determined that different standards for the admissibility of expert witness testimony apply. GSK Appeals Approval of Delaware Zantac Lawsuits While a number of different drug makers have been involved in the development and sale of the drug, GSK probably faces the majority of Delaware Zantac lawsuits and has aggressively fought the litigation, while other manufacturers have already agreed to settle claims to resolve their liability. In June 2024, Delaware Judge Vivian L. Medinilla rejected GSK’s attempt to dismiss tens of thousands of Zantac lawsuits filed in the state, finding that the challenged expert witness testimony was sufficiently reliable to allow a jury to consider the case. GSK filed a petition to the Supreme Court of Delaware, seeking certification of an interlocutory appeal, which would allow the drug maker to challenge the ruling before any final judgment is entered in individual Zantac lawsuits pending in that state. In an order (PDF) issued on August 27, Justice N. Christopher Griffiths granted the request for an immediate appeal, indicating that resolving the issue could be dispositive for nearly 75,000 Delaware Zantac lawsuits currently pending, as well as the continuing new claims that are being filed by former users diagnosed with cancer. “GSK plc welcomes today’s decision by the Delaware Supreme Court that it will review the Delaware Superior Court’s decision allowing the introduction of plaintiffs’ expert evidence at trial,” the company wrote in a press release issued yesterday. “The scientific consensus remains that there is no consistent or reliable evidence that ranitidine increases the risk of any cancer.” According to a schedule (PDF) issued by Delaware Supreme Court clerk Joanne K. Hastings on August 27, GSK’s opening brief must be filed by October 1, 2024, with any answers due 30 days later, and GSK’s final reply must be filed within 15 days after that. Delaware Zantac Lawsuits Continue to Be Filed While the parties await a ruling by the Delaware Supreme Court, plaintiffs continue to file new Zantac lawsuits in Delaware on a daily basis, each raising similar allegations that users developed cancers following long-term use of the heartburn drug. In one complaint (PDF) filed on August 19, Thomas Theys indicates that he developed prostate cancer as a result of using Zantac for just one year, from 2004 to 2005. In another complaint (PDF) filed the following day, Betty Jean Gross indicates that she developed esophageal cancer and prostate cancer after exposure to NDMA in Zantac, which she took from approximately 2013 until 2019. Both complaints maintain that GSK and other makers of generic versions of Zantac, including Boehringer Ingelheim, knew about the potential risks of Zantac cancer but consciously failed to warn the medical community and patients to protect profits. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Cancer, Delaware, GlaxoSmithKline, Heartburn, Heartburn Drug, NDMA, Zantac, Zantac Recall Image Credit: Tada Images More Zantac Lawsuit Stories Zantac Cancer Lawsuits Continue To Be Filed More Than 5 Years After Recall June 18, 2025 Jury Hears Zantac Cancer Evidence in Illinois Trial Against Boehringer Ingelheim February 5, 2025 Zantac Bladder Cancer Lawsuit Trial Ends With Hung Jury in California November 22, 2024 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermLinkedInThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Wayfair Fire Pit Lawsuit Links Flame Jetting Explosion to Defective Design (Posted: yesterday) In March 2026, a jury is scheduled to hear a Wayfair fire pit lawsuit from a woman who suffered burns to nearly half her body. MORE ABOUT: TABLETOP FIRE PIT LAWSUITAmazon Tabletop Fire Pit Lawsuit Alleges ‘Flame-Jetting’ Caused Third Degree Burns (08/29/2025)Tabletop Fire Pit Burn Victims Share Stories of Explosions and Devastating Injuries (08/21/2025)Colsen Fire Pit Lawsuit Involving Severe Burn Injuries Suffered by a Child Set for Trial Next Year (08/14/2025) Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (Posted: 2 days ago) Dupixent lawsuits are now being investigated after studies and FDA reports link Dupixent (dupilumab) to cutaneous T-cell lymphoma (CTCL). MORE ABOUT: DUPIXENT LAWSUITDupixent Side Effects May Increase Cutaneous T-Cell Lymphoma (CTCL) Risks (08/26/2025) Depo-Provera Meningioma Side Effects Significantly Increased Among Women Over 31: Study (Posted: 3 days ago) A new study appears to further confirm and quantify the risks of Depo-Provera meningioma side effects, potentially providing further evidence for growing litigation. MORE ABOUT: DEPO-PROVERA LAWSUITPfizer Seeks Dismissal of Depo-Provera Failure-To-Warn Lawsuits Over Meningioma Risks (09/02/2025)Nearly 1,000 Depo-Provera Meningioma Lawsuits Filed, With Another 9,500 Under Investigation (08/25/2025)Experts Weigh In On Depo-Provera Brain Tumor Risks, As Lawsuits Continue to Mount (08/20/2025)
Wayfair Fire Pit Lawsuit Links Flame Jetting Explosion to Defective Design (Posted: yesterday) In March 2026, a jury is scheduled to hear a Wayfair fire pit lawsuit from a woman who suffered burns to nearly half her body. MORE ABOUT: TABLETOP FIRE PIT LAWSUITAmazon Tabletop Fire Pit Lawsuit Alleges ‘Flame-Jetting’ Caused Third Degree Burns (08/29/2025)Tabletop Fire Pit Burn Victims Share Stories of Explosions and Devastating Injuries (08/21/2025)Colsen Fire Pit Lawsuit Involving Severe Burn Injuries Suffered by a Child Set for Trial Next Year (08/14/2025)
Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (Posted: 2 days ago) Dupixent lawsuits are now being investigated after studies and FDA reports link Dupixent (dupilumab) to cutaneous T-cell lymphoma (CTCL). MORE ABOUT: DUPIXENT LAWSUITDupixent Side Effects May Increase Cutaneous T-Cell Lymphoma (CTCL) Risks (08/26/2025)
Depo-Provera Meningioma Side Effects Significantly Increased Among Women Over 31: Study (Posted: 3 days ago) A new study appears to further confirm and quantify the risks of Depo-Provera meningioma side effects, potentially providing further evidence for growing litigation. MORE ABOUT: DEPO-PROVERA LAWSUITPfizer Seeks Dismissal of Depo-Provera Failure-To-Warn Lawsuits Over Meningioma Risks (09/02/2025)Nearly 1,000 Depo-Provera Meningioma Lawsuits Filed, With Another 9,500 Under Investigation (08/25/2025)Experts Weigh In On Depo-Provera Brain Tumor Risks, As Lawsuits Continue to Mount (08/20/2025)